FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

NCT02715518 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1292

Last updated 2024-04-17

No results posted yet for this study

Summary

The aim of the study is to compare clinical outcomes following fractional flow reserve (FFR)-guided versus angiography only guided strategy in treatment of non-infarction related artery (non-IRA) stenosis in patients with acute myocardial infarction (AMI) with multivessel disease

Prospective, open-label, randomized, multicenter trial to test the clinical outcomes following FFR-guided or angiography-guided strategy in treatment of non-IRA stenosis in patients with acute AMI with multivessel disease.

Conditions

  • Acute Myocardial Infarction

Interventions

DEVICE

PCI using 2nd generation drug-eluting stent

Percutaneous coronary intervention (PCI) using 2nd generation drug-eluting stent for non-IRA stenosis will be decided according to the allocated arms. 1. FFR-guided strategy arm 2. Angiography-guided strategy arm

Sponsors & Collaborators

  • Seoul National University Hospital

    collaborator OTHER
  • Inje University

    collaborator OTHER
  • Keimyung University Dongsan Medical Center

    collaborator OTHER
  • Sejong General Hospital

    collaborator OTHER
  • Wonju Severance Christian Hospital

    collaborator OTHER
  • Chungbuk National University Hospital

    collaborator OTHER
  • Chosun University Hospital

    collaborator OTHER
  • Inha University Hospital

    collaborator OTHER
  • Gyeongsang National University Hospital

    collaborator OTHER
  • KangWon National University Hospital

    collaborator OTHER
  • Incheon St.Mary's Hospital

    collaborator OTHER
  • Uijeongbu St. Mary Hospital

    collaborator OTHER
  • Ajou University School of Medicine

    collaborator OTHER
  • Chonnam National University Hospital

    collaborator OTHER
  • Kosin University Gospel Hospital

    collaborator OTHER
  • Samsung Changwon Hospital

    collaborator OTHER
  • Kangbuk Samsung Hospital

    collaborator OTHER
  • Yeungnam University Hospital

    collaborator OTHER
  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Joo-Yong Hahn, MD, PhD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-19
Primary Completion
2022-06-30
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02715518 on ClinicalTrials.gov